DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Food and Drug Andministration (FDA).
Draft Briefing Document for the Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
08.09.2011. NDA: 202439, Xarelto.
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm270796.pdf (letzter Zugriff 13.8.2013)
We do not assume any responsibility for the contents of the web pages of other providers.